RSV A RSV B Metapneumonia A B Multiplex Detection and Differentiation RNA Detection Qualitative Test
Overview
The RSV A RSV B Metapneumonia A B Multiplex Detection and Differentiation RNA Detection Qualitative Test is a diagnostic test offered by DNA Labs UAE. This test is used to detect and differentiate between respiratory syncytial virus (RSV) subtypes A and B, as well as metapneumonia viruses A and B. It is based on RNA detection and utilizes a multiplex polymerase chain reaction (PCR) technique to amplify and detect specific genetic material from these viruses.
Test Components
The test is priced at 2380.0 AED and requires the following sample conditions: Bronchial Swab, Bronchial Lavage, Sputum, Nasopharyngeal (NP) aspirates and swabs in viral transport medium, or lung tissues, etc.
Report Delivery
The test results are typically delivered via email within 4 working days or on the phone within 36 hours. The email report is usually sent within 48 hours.
Method and Test Type
The test uses Real Time PCR as the method and falls under the category of Viral tests.
Doctor and Test Department
The test is performed by a Physician in the Genetics department.
Pre Test Information
Prior to the test, patients need to sign a Consent document and bring any clinical history related to RSV A, RSV B, Metapneumonia A, B Multiplex Detection & Differentiation (RNA Detection) Qualitative Test.
Test Details
The RSV A RSV B Metapneumonia A B Multiplex Detection and Differentiation RNA Detection Qualitative Test is primarily used in clinical settings to aid in the diagnosis and management of respiratory infections. It is particularly useful in children and immunocompromised individuals who are at higher risk for severe illness.
By accurately identifying the specific viral subtypes causing the infection, healthcare providers can make informed decisions regarding treatment options and infection control measures. The test also helps differentiate between different respiratory infections with similar symptoms, allowing for appropriate patient management and prevention of unnecessary antibiotic use.
It is important to note that this test is performed in a laboratory setting and requires specialized equipment and trained personnel to perform and interpret the results accurately. Results are typically available within a few hours to a few days, depending on the laboratory’s testing capacity and workload.
| Test Name | RSV A RSV B Metapneumonia A B Multiplex Detection and Differentiation RNA Detection Qualitative Test |
|---|---|
| Components | |
| Price | 2380.0 AED |
| Sample Condition | Bronchial Swab, Bronchial Lavage, Sputum, Nasopharyngeal (NP) aspirates and swabs in viral transport medium, or lung tissues, ETC. |
| Report Delivery | 4th Working Day Email : 48 hours.On phone : 36 hours |
| Method | Real Time PCR |
| Test type | Viral |
| Doctor | Physician |
| Test Department: | Genetics |
| Pre Test Information | Need to sign Consent document and bring any clinical history of patient forRSV A, RSV B, Metapneumonia A, B Multiplex Detection & Differentiation (RNA Detection) QualitativeTest |
| Test Details | The RSV A, RSV B, Metapneumonia A, B Multiplex Detection & Differentiation (RNA Detection) Qualitative Test is a diagnostic test used to detect and differentiate between respiratory syncytial virus (RSV) subtypes A and B, as well as metapneumonia viruses A and B. This test is based on RNA detection and is used to identify the presence of these viral infections in respiratory samples, such as nasal swabs or bronchoalveolar lavage fluid. It utilizes a multiplex polymerase chain reaction (PCR) technique to amplify and detect specific genetic material from these viruses. The test provides qualitative results, indicating whether the target viruses are present or not. It is primarily used in clinical settings to aid in the diagnosis and management of respiratory infections, particularly in children and immunocompromised individuals who are at higher risk for severe illness. By accurately identifying the specific viral subtypes causing the infection, healthcare providers can make informed decisions regarding treatment options and infection control measures. Additionally, this test can help differentiate between different respiratory infections with similar symptoms, allowing for appropriate patient management and prevention of unnecessary antibiotic use. It is important to note that this test is performed in a laboratory setting and requires specialized equipment and trained personnel to perform and interpret the results accurately. Results are typically available within a few hours to a few days, depending on the laboratory’s testing capacity and workload. |
